USP 71 concerns sterility testing for microbial growth; USP 85 concerns bacterial endotoxins. Identity and HPLC purity answer different analytical questions. Each finding belongs to the sample, method and scope printed on its report. A percentage from a chromatogram cannot fill an absent sterility or endotoxin field.
This reference is for laboratories and business research teams reading analytical documents. It identifies the questions to keep separate and supplies a blank record-reading example. It assigns no testing attribute to a Glow Peptides material. Glow Peptides publishes the reference and supplies laboratory research materials; this is supplier-authored documentation.
What do USP 71 and USP 85 reports measure?
USP 71 and USP 85 name separate test subjects: microbial growth in a sterility test and bacterial endotoxins in an endotoxin test. A report reference to one chapter does not supply a result for the other. Identity evidence and chromatographic purity also remain separate entries in the analytical record.
USP publishes distinct records for Sterility Tests, chapter 71, and Bacterial Endotoxins Test, chapter 85. The titles identify the subject; the laboratory report identifies what was examined. For reading purposes, keep a separate row for each reported attribute rather than combining several methods into one general quality label.
| Reported attribute | Sample and report context | Wording or units to retain | What remains unknown without its own evidence |
|---|---|---|---|
| Sterility, USP 71 | The sampled units and the stated sterility method | The laboratory conclusion, observations and qualifications exactly as printed | Bacterial endotoxin status, chemical identity and chromatographic purity |
| Bacterial endotoxins, USP 85 | The named test sample, technique and reporting basis | The full result, comparator and unit, such as EU/mL when printed | Sterility and any broader statement about all contaminants |
| Bacterial endotoxins, USP 86 | The named recombinant technique and sample-specific scope | The chapter, reagent or technique, reported unit and qualifications | A USP 71 finding or an automatic equivalence with another report |
| Identity | The named material and the identity method | The reported match, assignment and reference information | Sterility, bacterial endotoxins and the extent of chromatographic impurities |
| HPLC purity | The chromatographic method, detector and reported basis | The percentage and the laboratory description of that percentage | A result for a different analytical attribute |
An empty cell means the reviewed document does not supply that finding. It does not establish that a test was never performed elsewhere, that a material passed, or that it failed. Keep those three possibilities separate when writing a summary.
What can a sterility report establish?
A sterility report records the conclusion for the examined sample under its stated test conditions. Preserve the sampled-unit context and any qualification attached to that conclusion. A statement about the examined units cannot by itself become an unqualified statement about every unit in a batch or a separate analytical attribute.
USP's public opening for chapter 1071 explicitly describes growth-based sterility tests and refers to chapter 71. That public passage supports the microbial-growth distinction used here; it supplies no finding for a Glow material.
USP makes the sampling limitation explicit in its December 2023 compounding FAQ, question 159: a sterility test does not guarantee whole-batch sterility. That FAQ concerns a particular compounding setting. Its numerical examples and batch rules are not specifications for research materials. The useful reading distinction here is between the tested units and the larger population.
When transcribing a report, retain the laboratory conclusion with its method and sample description. If a covering webpage says only that a certificate is available, open the certificate before assigning any sterility wording. An available document may contain identity or chromatography findings without a sterility finding.
A short extract can omit an important qualification that appears on another report page. Record the page count, review the complete document, and keep an unresolved qualification visible. A supplier heading, a laboratory name or the presence of a signature cannot replace the actual finding.
What does an endotoxin result actually describe?
An endotoxin result describes the bacterial endotoxin finding for the named sample on the report's stated basis. Preserve its numerical comparator, units, method and qualifications together. An unreported result remains unknown, and a value for one sample or reporting basis cannot be assigned to another material merely because their names resemble each other.
FDA's Pyrogen and Endotoxins Testing: Questions and Answers, Edition 2 is dated March 2026. It discusses method suitability, interference, detection limits and record context for regulated products. Those subjects explain why a reader needs the method and qualifications alongside a result. The guidance is not a universal acceptance specification for an unspecified laboratory research material.
Read the unit as part of the value. EU/mL expresses endotoxin units per milliliter; it is not a chromatographic percentage. Preserve a less-than sign rather than rewriting a bounded result as zero. If the report gives only a pass/fail conclusion, retain that conclusion and its printed criterion; do not invent the missing numerical result.
The report may refer to a separate method or appendix for its reporting basis. Record that reference and mark an unavailable appendix as unavailable. Do not calculate an acceptance limit or convert between reporting bases without the necessary source information. A missing basis is a question for the issuing laboratory.
Where does USP 86 fit in the report?
USP 86 adds bacterial endotoxin techniques using recombinant reagents. The public chapter preview names recombinant Factor C and recombinant cascade reagents and describes detection or quantification of endotoxins from Gram-negative bacteria. It also qualifies the alternative-test status of these methods unless specified in an individual monograph. A chapter number alone is therefore an incomplete description of a report.
The public USP 1085 introduction records the addition of chapter 86 in USP-NF 2025 Issue 1. Preserve a report's own chapter and edition reference rather than relabelling every endotoxin result as USP 85. Do not read a difference in chapter number as proof that either report is invalid.
For a document comparison, list the technique and the reported basis side by side. If equivalence between two methods matters to the comparison, keep the supporting comparison evidence as a separate record. Without that evidence, describe the methods as different reported methods and leave equivalence unresolved.
Why cannot HPLC purity replace these results?
HPLC purity describes a chromatographic measurement under a particular method. It does not report the microbial-growth observation of a sterility test or the bacterial endotoxin finding of a separate assay. A high percentage, a material name and a reference mass cannot supply missing test results, even when all appear on the same certificate.
The HPLC chromatogram reference explains peaks, detection and the scope of a reported percentage. The HPLC and mass spectrometry guide separates chromatographic and identity evidence. Those distinctions apply when reading a certificate, without extending either result into a general declaration about the material.
A catalog purity specification is a supplier statement about a standard. A measured finding is the laboratory's statement about its sample. Record which kind of statement is present before comparing it with another document. Neither kind of purity statement supplies an absent sterility or endotoxin result.
This separation also prevents a summary from becoming more certain than its sources. Instead of describing a certificate as complete because it carries a familiar percentage, enumerate the attributes actually reported and the fields not supplied. The resulting record is narrower, but another reader can reproduce it.
Which report fields must stay together?
Keep the document identity, sample identity, method and finding in the same record. Separating them makes it easy to attach a valid result to the wrong sample. Distinguish a supplier lot string from a laboratory sample identifier, and record any explicit connection supplied by the issuer.
- Document identity: issuer, report or accession number, version, page count and report date.
- Sample identity: exact material wording, sample identifier and any lot string printed in the report.
- Method identity: test name, chapter and edition where stated, technique, and referenced appendix.
- Finding: the exact conclusion or value, its unit, comparison sign and printed reporting basis.
- Scope: qualifications, missing pages, unavailable attachments and any explicitly limited interpretation.
- Source connection: document URL, issuer lookup reference if supplied, and the date the copies were compared.
A report date and the date a reader opened the file are different dates. Store both with clear labels. Likewise, a revised report can be newer than an earlier downloaded copy without the earlier file having been fabricated. Retain both versions and ask the issuer which version applies when the relationship is unclear.
If an issuer lookup is available, record its identifiers exactly. Where it shows a different date or conclusion, preserve the discrepancy rather than selecting whichever copy looks more favorable. The certificate-reading guide covers the wider document task; this reference focuses on keeping the test attributes separate.
How does an annotated report-reading example work?
Consider a hypothetical review folder with a supplier certificate and an issuer copy. The example below contains field labels and empty placeholders only. It is not a Glow lot, a laboratory report or a set of test findings. No numerical result, sample identifier or pass/fail conclusion has been invented.
| Record field | Entry in this example | Reading note |
|---|---|---|
| Issuer and report identifier | [not supplied in this example] | Transcribe both before joining the supplier and issuer copies. |
| Sample and lot wording | [not supplied in this example] | Keep separate strings where the report uses separate fields. |
| Sterility method and conclusion | [not supplied in this example] | Record only a finding explicitly present in the actual report. |
| Endotoxin method, result and unit | [not supplied in this example] | Keep the comparator, basis and qualification with the result. |
| Report date and version | [not supplied in this example] | Keep the source date separate from the comparison date. |
| Unresolved difference | [not supplied in this example] | Retain the difference and request issuer clarification. |
The reading decision depends on the actual populated fields. If the real certificate supplies only an HPLC result, an evidence summary can identify that result and state that the reviewed document supplies no sterility or endotoxin result. It cannot turn the empty fields into either a pass or a failure.
If both real copies name a sterility test but differ in their conclusion, the comparison remains unresolved. Keep the exact wording and page references from each. A matching logo or product name does not resolve a conflicting finding; clarification must come from the source.
What belongs in a reusable evidence record?
A reusable evidence record lets another reader find the same source and understand the same limits. A compact record is sufficient when it preserves the full finding and the connection to its sample. Use the checklist for document review, without using it as a laboratory method or a material-release decision.
- Identify the document and every page reviewed. Mark missing pages explicitly.
- Transcribe the issuer, report identifier, sample identifier and exact lot wording into separate fields.
- List each reported attribute on its own row, including the named method and any chapter reference.
- Copy the complete finding with its comparator, unit, basis and attached qualification.
- Record a missing field as not supplied by the reviewed document, without inferring a result.
- Attach the original source location, report version and date; record the comparison date separately.
- List discrepancies and unanswered source questions before writing a summary.
For repeat reviews, preserve the earlier record when a new source version arrives. A short change note can identify the replaced document and the fields that differ. Do not silently overwrite an unresolved question or carry a result forward merely because the supplier continues to use the same product name.
Where can I find related guides?
The USP 1503 quality-attribute reference covers the broader peptide attribute map. The testing-laboratory scope reference explains how to read published laboratory capabilities without assigning a test to a specific sample.
Glow's Quality and COA directory is the entry point for available Glow lot documents. A directory link establishes where to inspect the document; the document establishes what is reported. Keep any lot-specific conclusion attached to that lot's source rather than importing a general description from a reference article.
Frequently asked questions
Is USP 71 the same as USP 85?
No. USP 71 is Sterility Tests, and USP 85 is Bacterial Endotoxins Test. They describe different test subjects. Keep each reported method and finding separate, and do not fill an absent result by referring to the other chapter.
Does an endotoxin result establish sterility?
An endotoxin result is a finding about bacterial endotoxins under the stated method. It does not supply a sterility-test conclusion. Read a separate sterility finding, if present, with its sample description and qualifications; otherwise its status remains unknown from that document.
Can an HPLC purity percentage fill a missing test field?
No. A chromatographic percentage belongs to its analytical method and reporting basis. It cannot be transcribed into a sterility or endotoxin field. Record which attributes the reviewed report supplies and leave the other findings explicitly unreported.
Does a less-than result mean zero?
A less-than result states a bound on the reported finding. Keep the sign, number, unit and basis together rather than changing the result to zero. Preserve any associated reporting-limit explanation and ask the issuer about an unclear field.
Why might a report name USP 86 instead of USP 85?
USP 86 describes additional endotoxin techniques using recombinant reagents. Preserve the chapter and technique actually printed on the report. A different chapter reference is not, by itself, proof of a conflicting result or proof that two methods are equivalent.
What if the certificate has no sterility or endotoxin entry?
State that the reviewed certificate supplies no finding for that attribute. That does not establish whether testing exists in another document. It also supplies neither a pass nor a failure. Seek the missing source if the distinction matters to the record.
Does naming a USP chapter certify a Glow material?
This reference names test subjects and document fields. It certifies no material and assigns no USP conformance to a Glow lot. A chapter reference on a report must be read with that report's actual sample, findings and stated scope.
Which source should resolve different report copies?
Keep both copies, their versions, dates and exact differing fields. Ask the issuing laboratory to clarify the relationship and applicable version. Do not silently choose a favorable conclusion or assume that the more polished copy is the authoritative one.
Sources and scope notes
Source review: October 28, 2026. The USP chapter links are public previews, not the full current compendium. They support chapter identities and the scope visible in each preview. This reference reproduces no proprietary test procedure and is not a claim that the full current chapters were reviewed.
The December 2023 USP FAQ is cited only for its sampling limitation in its stated compounding context. FDA Edition 2 is March 2026 guidance for regulated products. Neither source supplies a numerical acceptance specification for an unspecified research material.
- USP 1071: public opening on growth-based sterility tests Public introduction explicitly references chapter 71; no procedural details reproduced.
- USP 71: Sterility Tests, public chapter preview Chapter identity and harmonization notice; complete text requires access.
- USP 85: Bacterial Endotoxins Test, public chapter preview Chapter identity; complete text requires access.
- USP 86: Bacterial Endotoxins Test Using Recombinant Reagents Public opening describes recombinant scope and alternative-test qualifications.
- USP 1085: Guidelines for Bacterial Endotoxins Testing Public introduction records chapter 86 in USP-NF 2025 Issue 1.
- FDA: Pyrogen and Endotoxins Testing, Questions and Answers, Edition 2 March 2026; method and report context for regulated products.
- USP compounding FAQ, December 11, 2023, question 159 Page 31, printed page number; the distinction between tested units and a whole batch.